Serum and urinary strontium levels and possible interference with measurement of other minerals in subjects taking Strontium ranelate (Protelos) for osteoporosis.

Trial Profile

Serum and urinary strontium levels and possible interference with measurement of other minerals in subjects taking Strontium ranelate (Protelos) for osteoporosis.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 11 Oct 2012

At a glance

  • Drugs Strontium ranelate (Primary)
  • Indications Osteoporosis
  • Focus Pharmacodynamics
  • Acronyms SR-SJI/AM
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 11 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top